Global Bioresearch Solutions Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-12-2024
- Paid Up Capital ₹ 0.10 M
as on 17-12-2024
- Company Age 8 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.50 M
as on 17-12-2024
- Revenue 13.81%
(FY 2023)
- Profit 17.08%
(FY 2023)
- Ebitda 200.33%
(FY 2023)
- Net Worth 45.01%
(FY 2023)
- Total Assets 19.38%
(FY 2023)
About Global Bioresearch Solutions
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.50 M.
Ajit Jagtap and Sharad Nandkumar serve as directors at the Company.
- CIN/LLPIN
U85200PN2016PTC158405
- Company No.
158405
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2016
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Satara, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Global Bioresearch Solutions?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ajit Jagtap  | Director | 13-Feb-2016 | Current |
| Sharad Nandkumar | Director | 13-Feb-2016 | Current |
Financial Performance of Global Bioresearch Solutions.
Global Bioresearch Solutions Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 13.81% increase. The company also saw a substantial improvement in profitability, with a 17.08% increase in profit. The company's net worth Soared by an impressive increase of 45.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Global Bioresearch Solutions?
Unlock access to Global Bioresearch Solutions's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹3.50 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Mar 2023 | Others | ₹3.50 M | Open |
How Many Employees Work at Global Bioresearch Solutions?
Unlock and access historical data on people associated with Global Bioresearch Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Global Bioresearch Solutions, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Global Bioresearch Solutions's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.